CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Gain (Loss) on Disposition of Assets
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Gain (Loss) on Disposition of Assets of $38.48 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-05
- 2026-06-27: Gain (Loss) on Disposition of Assets 6 month $38.48M.
- 2025-06-28: Gain (Loss) on Disposition of Assets 6 month $0.00.
| Period end | Gain (Loss) on Disposition of Assets 6 month |
|---|---|
| 2026-06-27 | $38.48M 10-Q · filed 2026-08-05 |
| 2025-06-28 | $0.00 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |